China's Expertise in Diabetes Care
China has one of the largest diabetic populations in the world, with over 140 million people living with the condition. This scale has driven enormous investment in diabetes research, specialist training, and clinical infrastructure. As a result, China's leading hospitals offer diabetes management programmes that are genuinely world-class — combining endocrinology, nutrition, technology, and patient education in integrated care pathways.
For international patients seeking specialist diabetes assessment, medication adjustment, or access to newer therapies not yet available in their home country, China presents a compelling option.
Types of Diabetes Treatment Available
Type 1 Diabetes Management
Leading Chinese hospitals offer comprehensive Type 1 diabetes care including continuous glucose monitoring (CGM), insulin pump therapy (CSII), and structured patient education programmes. Specialist endocrinology teams manage complex cases including brittle diabetes and those with significant complications.
Type 2 Diabetes Treatment
Treatment for Type 2 diabetes in China follows international guidelines and includes lifestyle intervention, oral medications, GLP-1 receptor agonists, SGLT-2 inhibitors, and insulin therapy where required. Many hospitals run dedicated metabolic disease clinics that address diabetes alongside obesity, hypertension, and dyslipidaemia as interconnected conditions.
Metabolic Surgery for Diabetes
Bariatric and metabolic surgery — including sleeve gastrectomy and Roux-en-Y gastric bypass — is offered at specialist centres as a treatment for Type 2 diabetes in patients with obesity. China has published strong outcome data in this area, and costs are significantly lower than in Western countries.
Traditional Chinese Medicine Integration
Some hospitals offer integrative programmes that combine conventional diabetes management with Traditional Chinese Medicine (TCM) approaches, including herbal formulations and acupuncture. Evidence for TCM in diabetes is mixed, but integrated programmes at reputable hospitals are conducted under rigorous clinical oversight.
Leading Hospitals for Diabetes Treatment
Shanghai Sixth People's Hospital
Shanghai Sixth People's Hospital is arguably China's most renowned institution for diabetes and endocrinology. Its diabetes centre has a long history of research and clinical excellence, and it is a national reference centre for diabetic complications including retinopathy, nephropathy, and neuropathy. The hospital has an established international patient department.
Peking Union Medical College Hospital, Beijing
PUMCH's endocrinology department is one of China's most respected, with deep expertise in complex and rare endocrine disorders alongside mainstream diabetes management. It is a strong choice for patients with complicated presentations or multiple comorbidities.
West China Hospital, Chengdu
West China Hospital's endocrinology and metabolism department handles a very high patient volume and offers comprehensive diabetes services at costs lower than Beijing or Shanghai equivalents.
Diagnostic Assessments Available
A thorough diabetes assessment at a leading Chinese hospital typically includes:
- HbA1c and fasting glucose — baseline glycaemic control
- C-peptide and insulin levels — assessing residual beta-cell function
- Lipid panel and kidney function tests — cardiovascular and renal risk assessment
- Urine microalbumin — early diabetic nephropathy detection
- Retinal photography — diabetic retinopathy screening
- Nerve conduction studies — peripheral neuropathy assessment
- Continuous glucose monitoring (CGM) — detailed glycaemic profiling over 14 days
Cost Overview
Costs vary by hospital tier and the complexity of assessment or treatment required:
- Outpatient consultation (endocrinologist): ¥300–¥800 (approx. USD 42–112)
- Comprehensive diabetes assessment package: ¥3,000–¥8,000 (approx. USD 420–1,100)
- 14-day CGM sensor and report: ¥800–¥1,500 (approx. USD 112–210)
- Insulin pump initiation and training: ¥5,000–¥15,000 (approx. USD 700–2,100)
Medications in China are generally priced lower than in Western markets. GLP-1 agonists and SGLT-2 inhibitors, which can be expensive in the US and Europe, are available at substantially reduced cost.
Tips for International Patients
- Bring complete records: Share your current medication list, recent HbA1c results, and any complication history before your consultation.
- Clarify medication continuity: Confirm which medications you can take home and whether prescriptions will be provided in a format recognised in your home country.
- Plan for follow-up: Agree on a remote follow-up plan with your Chinese care team so continuity is maintained after you return home.
- Device compatibility: If you use a CGM or insulin pump, check device compatibility and consumable availability in China before travelling.
China's investment in diabetes research means patients here often have access to clinical trials and emerging therapies before they become widely available elsewhere. Ask your care team about any relevant studies you may be eligible to join.
Disclaimer
This article is for informational purposes only and does not constitute medical advice. Diabetes management must be individualised and supervised by a qualified endocrinologist or physician. Do not adjust medications without professional guidance. Costs are indicative and subject to change.
Connect with Diabetes Specialists in China
Use SeeDocInChina to find verified endocrinology departments and diabetes clinics across China. Compare hospitals, review international patient services, and get in touch with coordinators who can help you plan your visit.